Furthermore, GPER1 stimulation by tamoxifen [acting as an agonist on this receptor (2)] inhibits the myofibroblastic differentiation of pancreatic stellate cells in the tumor microenvironment of pancreatic tumors, hampering their ability to remodel the extracellular matrix and to promote cancer cell invasion. The gene discussed is GPER1; the disease is cancer.